mision_1

Q8: Are there attractive drug targets in the viruses genome like integrase and reverse transcriptase in HIV?

Q8: Are there attractive drug targets in the viruses genome like integrase and reverse transcriptase in HIV?

There have not been enough studies yet to understand the Ebola virus replication well enough to identify man of these sites or processes. There are no integrases or RTs because the RNA virus does not have a DNA step or integrate into cellular genetic material. However, there may be sites yet to be discovered or understood as drug targets.

Q10: What exactly is in the treatment, Zmapp serum, used for the two Ebola patients brought to the US? Zmapp contains a humanized monoclonal antibody (combination of regions from a human protein and a mouse or rabbit). It is made against a region of the virus protein that contacts the cell. The antibody is made to high levels in a virus produced and purified from tobacco leaves. It is placed in serum from an Ebola patient when possible. (Will check on use of human serum).

Q11: Explain why it was important bring the 2 patients to US and flex the treatment protocols at Emory? Continue reading “Q8: Are there attractive drug targets in the viruses genome like integrase and reverse transcriptase in HIV?”